- Home
- MYND vs ATRA Comparison
MYND vs ATRA Comparison
Compare MYND & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- ATRA
- Stock Information
- Founded
- MYND 1998
- ATRA 2012
- Country
- MYND United States
- ATRA United States
- Employees
- MYND N/A
- ATRA N/A
- Industry
- MYND Other Consumer Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYND Real Estate
- ATRA Health Care
- Exchange
- MYND Nasdaq
- ATRA Nasdaq
- Market Cap
- MYND 42.3M
- ATRA 40.1M
- IPO Year
- MYND 2017
- ATRA 2014
- Fundamental
- Price
- MYND $0.90
- ATRA $8.47
- Analyst Decision
- MYND
- ATRA Buy
- Analyst Count
- MYND 0
- ATRA 5
- Target Price
- MYND N/A
- ATRA $17.75
- AVG Volume (30 Days)
- MYND 14.2K
- ATRA 41.2K
- Earning Date
- MYND 08-28-2025
- ATRA 08-11-2025
- Dividend Yield
- MYND N/A
- ATRA N/A
- EPS Growth
- MYND N/A
- ATRA N/A
- EPS
- MYND N/A
- ATRA N/A
- Revenue
- MYND $267,380,999.00
- ATRA $199,732,000.00
- Revenue This Year
- MYND N/A
- ATRA N/A
- Revenue Next Year
- MYND N/A
- ATRA N/A
- P/E Ratio
- MYND N/A
- ATRA N/A
- Revenue Growth
- MYND N/A
- ATRA 475.53
- 52 Week Low
- MYND $0.61
- ATRA $5.01
- 52 Week High
- MYND $3.89
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- MYND 50.43
- ATRA 57.82
- Support Level
- MYND $0.83
- ATRA $7.54
- Resistance Level
- MYND $0.97
- ATRA $8.25
- Average True Range (ATR)
- MYND 0.10
- ATRA 0.48
- MACD
- MYND -0.01
- ATRA -0.04
- Stochastic Oscillator
- MYND 47.37
- ATRA 64.09
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).